HomeNATCOPHARM • NSE
add
Natco Pharma Ltd.
Previous close
₹1,382.90
Day range
₹1,385.85 - ₹1,423.00
Year range
₹724.20 - ₹1,639.00
Market cap
253.44B INR
Avg Volume
947.94K
P/E ratio
15.49
Dividend yield
0.39%
Primary exchange
NSE
Market news
Financials
Income Statement
Revenue
Net income
| (INR) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 13.63B | 19.47% |
Operating expense | 4.22B | 3.11% |
Net income | 6.68B | 59.05% |
Net profit margin | 49.06 | 33.13% |
Earnings per share | 37.32 | 60.45% |
EBITDA | 8.07B | 40.06% |
Effective tax rate | 16.81% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 18.49B | 59.13% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 58.53B | — |
Shares outstanding | 179.13M | — |
Price to book | 4.23 | — |
Return on assets | — | — |
Return on capital | 30.55% | — |
Cash Flow
Net change in cash
| (INR) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | 6.68B | 59.05% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Natco Pharma is an Indian multinational pharmaceutical company based in Hyderabad. The company manufactures finished dosage formulations active pharmaceutical ingredients and Agro chemical products. It is a major producer of branded oncology medicines cardiology, diabetology and other pharma specialty drugs. The company specialises in producing complex medicines at affordable prices. NATCO is a science driven company and focuses on limited competition molecules in the US. Wikipedia
Founded
1981
Headquarters
Website
Employees
4,016
